"The daily pills nearly doubled survival time, with fewer "severe" side effects" (It has plenty of severe side effects , "but fewer"
"those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients"
Revolution Medicines wants 30bil for this drug that focuses on one kras mutation
Im thinking we blow Revolution data out the water once we do the ici combo thing.
And then maybe we get a little press.